Hans Anton Schloesser, Anja Lohneis, Maria Garcia-Marquez, Martin Thelen, Petra Schiller, Kerstin Rosenberger, Kerstin Wennhold, Seung-Hun Chon, Eugen Bauer, Loreen S. Rudek, Philipp Linde, Naita M. Wirsik, Hans F. Fuchs, Lars M. Schiffmann, Reinhard Buettner, Martin Hellmich, Michael Von Bergwelt, Axel M. Hillmer, Christiane J. Bruns, Thomas Zander. "Perioperative durvalumab plus neoadjuvant chemoradiotherapy (CROSS) with and without tremelimumab in esophageal adenocarcinoma: The prospective phase II RICE trial (NCT04159974).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4083